To use this site, please disable the ad blocking feature and reload the page.
This website uses cookies to collect information about your visit for purposes such as showing you personalized ads and content, and analyzing our website traffic. By clicking “Accept all,” you will allow the use of these cookies.
Users accessing this site from EEA countries and UK are unable to view this site without your consent. We apologize for any inconvenience caused.
Courtesy of Bandar Algaloud/Saudi Royal Court/Handout via REUTERS Saudi King Salman bin Abdulaziz gives a virtual speech during an opening session of the 15th annual G20 Leaders’ Summit in Riyadh, Saudi Arabia, November 21, 2020.
Reuters
11:50 JST, May 20, 2024
DUBAI (Reuters) – Saudi King Salman will undergo a treatment program at Al Salam Palace in Jeddah for a lung inflammation, the state news agency said on Sunday, hours after he underwent medical tests.
Citing the royal court, the state news agency said the 88-year-old king would be treated with antibiotics until the inflammation subsides.
Due to King Salman’s health issue, Crown Prince Mohammed bin Salman postponed a visit to Japan that had been scheduled to begin on Monday, Japan’s Chief Cabinet Secretary Yoshimasa Hayashi said.
Earlier on Sunday, King Salman underwent medical tests at the royal clinics at Al Salam Palace due to “high temperature and joint pain,” the state news agency said.
The king was last admitted to hospital in April for a routine checkup, state TV reported then.
King Salman, the custodian of Islam’s holiest sites, became ruler of the world’s top oil exporter in 2015 after spending more than 2-1/2 years as the crown prince and deputy premier.
